Closing the indigenous health gap in Canada: Results from the TransFORmation of IndiGEnous PrimAry HEAlthcare delivery (FORGE AHEAD) program.

Chronic disease Community-driven Diabetes First nations Indigenous peoples Quality improvement (QI)

Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 21 10 2019
revised: 13 01 2020
accepted: 06 02 2020
pubmed: 12 2 2020
medline: 24 7 2020
entrez: 12 2 2020
Statut: ppublish

Résumé

TransFORmation of IndiGEnous PrimAry HEAlthcare Delivery (FORGE AHEAD) partnered with local clinical and community teams in 11 First Nations (FN) communities across Canada to develop quality improvement (QI) initiatives aimed at improving T2DM. Pre-post mixed-methods case study design was used. The 18-month intervention included community and clinical readiness, development of a community diabetes registry and clinical system, and QI activities. Participants consisted of community members, 18 yrs and older, with diabetes. Changes in clinical outcomes and clinical practice guideline (CPG) recommendations were assessed pre and post intervention using multilevel regression (patients nested within communities) adjusted forindividual andcommunity baseline characteristics. No significant change in HbA1c orsBP, but a small reduction indBP(-0.75 mmHg, p < 0.05) and LDL (-0.09 mmol/L, p < 0.05) was observed in 2008 adults with T2DM (mean age: 60·5 (SD:14·6) years; female: 57·2%). Individuals not at CPG targets at baseline had significant reductions in: %HbA1c (N = 616): -0.40 (95%CI:-0·55,-0·24),sBP (N = 561): -7·67 mmHg (95%CI:-9·23, -5·72),dBP (N = 291): -7·46 mmHg (95%CI:-8·69, -6·26), LDL (N = 450): -0·37mmo/l (95%CI:-0·44, -0·29).Annual HbA1c (OR: 1·95; 95%CI:1·66, 2·29), BP (OR: 1·78; 95%CI:1·52, 2·09), LDL (OR: 1·27; 95%CI:1·10, 1·47) and CKD screening (OR: 6·37; 95%CI:5·16, 7·92)increased but retinopathy screening decreased (OR: 0·68; 95%CI:0·57, 0·82). No significant change in foot exams (OR: 0·97; 95%CI:0·76, 1·23) or BMI recordings (OR: 0·96; 95%CI:0·82, 1·12) was seen. Overall, individualsweremorelikely to receive ≥75% of CPG recommended services compared to baseline (OR: 1·51; 95%CI:1·27, 1·80). FORGE AHEAD is the first Canadian study to demonstrate that a FN community-led QI intervention can lead to diabetes improvements.

Identifiants

pubmed: 32045618
pii: S0168-8227(19)31457-3
doi: 10.1016/j.diabres.2020.108066
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108066

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest MNH, HZ, and SH were funded from the grant supporting this study. All remaining authors declare that they have no competing interests.

Auteurs

Mariam Naqshbandi Hayward (MN)

Research Western, Western University, London, ON, Canada. Electronic address: Mariam.Hayward@uwo.ca.

Romina Pace (R)

Centre for Outcomes Research & Evaluation, Research Institute, McGill University Health Centre, Montreal, QC, Canada.

Harsh Zaran (H)

Centre for Studies in Family Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

Roland Dyck (R)

College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

Anthony J Hanley (AJ)

Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada.

Michael E Green (ME)

Department of Family Medicine, Public Health Sciences and Policy Studies, and Health Services and Policy Research Institute, Queen's University, Kingston, ON, Canada.

Onil Bhattacharyya (O)

Women's College Hospital, Department of Family and Community Medicine, University of Toronto and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Merrick Zwarenstein (M)

Centre for Studies in Family Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

Joelle Emond (J)

Kateri Memorial Hospital Centre, Kahnawake Mohawk Territory, QC, Canada.

Cynthia Benoit (C)

Conne River Health and Social Services, Conne River, NL, Canada.

Marie L Jebb (ML)

Beatrice Wilson Health Centre, Opaskwayak Health Authority, Opaskwayak Cree Nation, Opaskwayak, MB, Canada.

Stewart B Harris (SB)

Centre for Studies in Family Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH